|
1
|
Vasectomy and risk of aggressive prostate cancer: a 24-year follow-up study.
|
J Clin Oncol
|
2014
|
4.67
|
|
2
|
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.
|
J Natl Cancer Inst
|
2008
|
3.55
|
|
3
|
Telomere length predicts survival independent of genetic influences.
|
Aging Cell
|
2007
|
3.01
|
|
4
|
Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?
|
J Clin Oncol
|
2009
|
2.94
|
|
5
|
Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study.
|
J Natl Cancer Inst
|
2011
|
2.85
|
|
6
|
Average energy intake among pregnant women carrying a boy compared with a girl.
|
BMJ
|
2003
|
2.55
|
|
7
|
Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study.
|
J Natl Cancer Inst
|
2009
|
2.50
|
|
8
|
Molecular sampling of prostate cancer: a dilemma for predicting disease progression.
|
BMC Med Genomics
|
2010
|
2.40
|
|
9
|
A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
|
PLoS Med
|
2007
|
2.20
|
|
10
|
Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States.
|
J Natl Cancer Inst
|
2010
|
2.18
|
|
11
|
The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
2.13
|
|
12
|
A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival.
|
Cancer Prev Res (Phila)
|
2010
|
1.92
|
|
13
|
ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients.
|
Genes Dev
|
2013
|
1.87
|
|
14
|
Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study.
|
J Natl Cancer Inst
|
2012
|
1.79
|
|
15
|
Temporal trends in cause of death among Swedish and US men with prostate cancer.
|
J Natl Cancer Inst
|
2012
|
1.50
|
|
16
|
Fish consumption and prostate cancer risk: a review and meta-analysis.
|
Am J Clin Nutr
|
2010
|
1.48
|
|
17
|
Consumption of fish products across the lifespan and prostate cancer risk.
|
PLoS One
|
2013
|
1.46
|
|
18
|
Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis.
|
PLoS Genet
|
2010
|
1.40
|
|
19
|
mRNA expression signature of Gleason grade predicts lethal prostate cancer.
|
J Clin Oncol
|
2011
|
1.40
|
|
20
|
Vitamin D receptor protein expression in tumor tissue and prostate cancer progression.
|
J Clin Oncol
|
2011
|
1.39
|
|
21
|
Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival.
|
J Clin Oncol
|
2010
|
1.37
|
|
22
|
Circadian disruption, sleep loss, and prostate cancer risk: a systematic review of epidemiologic studies.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
1.35
|
|
23
|
Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality.
|
Int J Cancer
|
2009
|
1.29
|
|
24
|
Immediate risk for cardiovascular events and suicide following a prostate cancer diagnosis: prospective cohort study.
|
PLoS Med
|
2009
|
1.26
|
|
25
|
Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer.
|
PLoS One
|
2011
|
1.25
|
|
26
|
Genome-wide association study of prostate cancer mortality.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.21
|
|
27
|
Lifestyle and dietary factors in the prevention of lethal prostate cancer.
|
Asian J Androl
|
2012
|
1.19
|
|
28
|
Nausea and vomiting in pregnancy in relation to prolactin, estrogens, and progesterone: a prospective study.
|
Obstet Gynecol
|
2003
|
1.14
|
|
29
|
Genetic variation in RNASEL associated with prostate cancer risk and progression.
|
Carcinogenesis
|
2010
|
1.12
|
|
30
|
Sleep disruption among older men and risk of prostate cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
1.10
|
|
31
|
Gleason grade progression is uncommon.
|
Cancer Res
|
2013
|
1.09
|
|
32
|
Milk and dairy consumption among men with prostate cancer and risk of metastases and prostate cancer death.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
1.05
|
|
33
|
Validity and reliability of self-reported total energy expenditure using a novel instrument.
|
Eur J Epidemiol
|
2006
|
1.05
|
|
34
|
Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
1.04
|
|
35
|
Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels.
|
Carcinogenesis
|
2011
|
1.04
|
|
36
|
Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death.
|
Cancer Discov
|
2013
|
1.03
|
|
37
|
Aberrant cytoplasmic expression of p63 and prostate cancer mortality.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.03
|
|
38
|
Inflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.03
|
|
39
|
Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.02
|
|
40
|
Dietary fatty acid intake and prostate cancer survival in Örebro County, Sweden.
|
Am J Epidemiol
|
2012
|
1.01
|
|
41
|
A prospective study on dietary acrylamide intake and the risk for breast, endometrial, and ovarian cancers.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.00
|
|
42
|
Toll-like receptor signaling pathway variants and prostate cancer mortality.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
0.99
|
|
43
|
Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG.
|
J Natl Cancer Inst
|
2013
|
0.97
|
|
44
|
Dietary acrylamide intake and risk of premenopausal breast cancer.
|
Am J Epidemiol
|
2009
|
0.97
|
|
45
|
Maternal smoking during pregnancy and risk of brain tumors in the offspring. A prospective study of 1.4 million Swedish births.
|
Cancer Causes Control
|
2004
|
0.96
|
|
46
|
Acrylamide intake and breast cancer risk in Swedish women.
|
JAMA
|
2005
|
0.95
|
|
47
|
Physical activity as a determinant of mortality in women.
|
Epidemiology
|
2005
|
0.95
|
|
48
|
Prognostic determinants in prostate cancer.
|
Cancer J
|
2011
|
0.95
|
|
49
|
Test-retest reliability of colorectal testing questions on the Massachusetts Behavioral Risk Factor Surveillance System (BRFSS).
|
Prev Med
|
2005
|
0.94
|
|
50
|
Dietary zinc and prostate cancer survival in a Swedish cohort.
|
Am J Clin Nutr
|
2011
|
0.94
|
|
51
|
A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer.
|
Clin Cancer Res
|
2013
|
0.93
|
|
52
|
Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.93
|
|
53
|
Prostate cancer risk and ESR1 TA, ESR2 CA repeat polymorphisms.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.93
|
|
54
|
One-carbon metabolism-related nutrients and prostate cancer survival.
|
Am J Clin Nutr
|
2009
|
0.91
|
|
55
|
Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer.
|
Carcinogenesis
|
2011
|
0.90
|
|
56
|
Coffee and risk of prostate cancer incidence and mortality in the Cancer of the Prostate in Sweden Study.
|
Cancer Causes Control
|
2013
|
0.90
|
|
57
|
The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer.
|
Prostate
|
2015
|
0.88
|
|
58
|
An exploration of shared genetic risk factors between periodontal disease and cancers: a prospective co-twin study.
|
Am J Epidemiol
|
2009
|
0.88
|
|
59
|
Acrylamide exposure measured by food frequency questionnaire and hemoglobin adduct levels and prostate cancer risk in the Cancer of the Prostate in Sweden Study.
|
Int J Cancer
|
2009
|
0.87
|
|
60
|
Common genetic variation of the calcium-sensing receptor and lethal prostate cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.86
|
|
61
|
RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
|
J Natl Cancer Inst
|
2014
|
0.86
|
|
62
|
Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality.
|
Prostate
|
2011
|
0.85
|
|
63
|
Homogeneous prostate cancer mortality in the Nordic countries over four decades.
|
Eur Urol
|
2010
|
0.85
|
|
64
|
Total antioxidant intake in relation to prostate cancer incidence in the Health Professionals Follow-Up Study.
|
Int J Cancer
|
2013
|
0.85
|
|
65
|
The plight of the potato: is dietary acrylamide a risk factor for human cancer?
|
J Natl Cancer Inst
|
2009
|
0.84
|
|
66
|
Selenoprotein P genetic variants and mrna expression, circulating selenium, and prostate cancer risk and survival.
|
Prostate
|
2012
|
0.84
|
|
67
|
Lifetime body size and prostate cancer risk in a population-based case-control study in Sweden.
|
Cancer Causes Control
|
2013
|
0.82
|
|
68
|
Associations between dietary acrylamide intake and plasma sex hormone levels.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.81
|
|
69
|
α-Methylacyl-CoA racemase expression and lethal prostate cancer in the Physicians' Health Study and Health Professionals Follow-up Study.
|
Prostate
|
2011
|
0.81
|
|
70
|
Beta-carotene antioxidant use during radiation therapy and prostate cancer outcome in the Physicians' Health Study.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.80
|
|
71
|
Dietary acrylamide and risk of prostate cancer.
|
Int J Cancer
|
2011
|
0.80
|
|
72
|
Interrogation of ERG gene rearrangements in prostate cancer identifies a prognostic 10-gene signature with relevant implication to patients' clinical outcome.
|
BJU Int
|
2013
|
0.80
|
|
73
|
Watchful waiting and quality of life among prostate cancer survivors in the Physicians' Health Study.
|
J Urol
|
2011
|
0.79
|
|
74
|
Circadian clock genes and risk of fatal prostate cancer.
|
Cancer Causes Control
|
2014
|
0.79
|
|
75
|
Placental weight and risk of invasive epithelial ovarian cancer with an early age of onset.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
0.79
|
|
76
|
Screening for bladder cancer: theoretical and practical issues in considering the treated and untreated natural history of the various forms of the disease.
|
Scand J Urol Nephrol Suppl
|
2008
|
0.79
|
|
77
|
Gender of offspring and maternal risk of invasive epithelial ovarian cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.79
|
|
78
|
Identifying Health Maintenance Organization membership through self-report of health plan name: ascertainment and reliability.
|
J Public Health Manag Pract
|
2006
|
0.79
|
|
79
|
Vitamin D and prostate cancer risk--a less sunny outlook?
|
J Natl Cancer Inst
|
2008
|
0.78
|
|
80
|
Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue.
|
Cancer Causes Control
|
2012
|
0.77
|
|
81
|
Alcohol influence on acrylamide to glycidamide metabolism assessed with hemoglobin-adducts and questionnaire data.
|
Food Chem Toxicol
|
2009
|
0.77
|
|
82
|
Genetic variation across C-reactive protein and risk of prostate cancer.
|
Prostate
|
2014
|
0.75
|
|
83
|
Birth spacing and maternal risk of invasive epithelial ovarian cancer in a Swedish nationwide cohort.
|
Cancer Causes Control
|
2008
|
0.75
|
|
84
|
The Nordic Nutrition Recommendations and prostate cancer risk in the Cancer of the Prostate in Sweden (CAPS) study.
|
Public Health Nutr
|
2012
|
0.75
|